Aveva 250 mg Injection 5 ml Substitute
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by AYUR
Composition:
FULVESTRANT-250MG
Uses:
Aveva 250 mg Injection 5 ml is used in the treatment of Breast cancer in postmenopausal women. The detailed uses of Aveva 250 mg Injection 5 ml are as follows:<br/>• Treatment of breast cancer: Aveva 250 mg Injection 5 ml is used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in postmenopausal women.<br/>• Treatment of progressed cancer: Aveva 250 mg Injection 5 ml is prescribed when the cancer has progressed following prior endocrine therapy.<br/>
Medicinal Benefits:
Aveva 250 mg Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Aveva 250 mg Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).
Aveva 250 mg Injection 5 ml is used to treat Breast cancer in postmenopausal women.
Aveva 250 mg Injection 5 ml contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Aveva 250 mg Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Aveva 250 mg Injection 5 ml.
Aveva 250 mg Injection 5 ml may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.
Aveva 250 mg Injection 5 ml contains Fulvestrant, which belongs to a class of medications called estrogen receptor antagonists. It helps to slow or stop the growth of specific breast tumours that depend on estrogen (a female sex hormone) to grow.
Aveva 250 mg Injection 5 ml is administered as a liquid injection into a muscle in the buttocks by a doctor in a medical setting. It is typically injected slowly over 1 to 2 minutes. For the first three doses, you will receive an injection every two weeks (on days 1, 15, and 29). After that, it is usually given once a month. Your doctor will determine the exact schedule based on your condition and how you respond to the medication. The injection will be given as two separate shots (one in each buttock). Please do not self-administer it.
Aveva 250 mg Injection 5 ml may cause common side effects, such as injection site reactions like pain and inflammation, weakness, nausea, tiredness, headache, or joint and musculoskeletal pain in some individuals. Most of these side effects of Aveva 250 mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.